Close
  Indian J Med Microbiol
 

Figure 4: Results of lactic acid (lactate) assessment in KYSE 30 cells following single and combined treated cases with EGCG and CP after 24 h in esophageal cancer cells. Data are presented as mean ± SD. *P < 0.05 and **P < 0.01 indicate significant differences compared to the untreated control, #P < 0.05versus EGCG (IC50), and $P < 0.05 against CP (IC50) group. CP, Carboplatin; EGCG, epigallocatechin-3-gallate

Figure 4: Results of lactic acid (lactate) assessment in KYSE 30 cells following single and combined treated cases with EGCG and CP after 24 h in esophageal cancer cells. Data are presented as mean ± SD. *<i>P</i> < 0.05 and <i>**P</i> < 0.01 indicate significant differences compared to the untreated control, <i><sup>#</sup>P</i> < 0.05versus EGCG (IC<sub>50</sub>), and <i><sup>$</sup>P</i> < 0.05 against CP (IC<sub>50</sub>) group. CP, Carboplatin; EGCG, epigallocatechin-3-gallate